Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teijin Inks Deal With SanBio For Stroke Drug
Based on the results of pre-clinical and clinical trials conducted by SanBio, Teijin plans to begin clinical trials in Japan. SanBio developed SB623 by processing bone marrow from
Based on the results of pre-clinical and clinical trials conducted by SanBio, Teijin plans to begin clinical trials in Japan. SanBio developed SB623 by processing bone marrow from
Currently, the most widely-used treatment for type 1 diabetes is the regular injection of insulin, a burdensome task for patients. Islet cell transplantation, whereby insulin-producing cells from a
As per the agreement, BioMarin will pay LEAD $18m upfront and will pay an additional $11m upon acceptance of the IND filing (filing expected by the end of
Voclosporin, a calcineurin inhibitor, is proposed for the treatment of non-infectious uveitis, involving the posterior segment of the eye. Its the leading cause of vision loss and long-term
Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for US-based customers. The company’s future plans call for an increased capacity to develop and submit New Drug
The orphan drug designation potentially may provide AVI up to ten years of market exclusivity, if the drug candidate is approved for marketing in the EU. AVI-4658, another
The new drug application (NDA) for Zuplenz was accepted for review by the FDA in June 2009, and a response is expected in the first quarter of 2010
The injection is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. Feraheme is contraindicated in patients with evidence of iron overload,
Reportedly, Alpha1-Proteinase Inhibitor (Human, A1PI) will be an aerosol formulation. Talecris has also received an orphan drug designation for the aerosolized form of AAT from the European Commission
Together with many other pharmaceutical manufacturers, Teva is named in numerous civil lawsuits that relate to drug price reporting by manufacturers in about 15 states. The cases, which